N. Li

Li, N., Majoie, M., Evers, S., Rijkers, K., Gubler, F., Rouhl, R., Lazeron, R., Klarenbeek, P., Laskier-Owens, V., & Hiligsmann, M. (2025). Budget impact analysis of cenobamate for epilepsy patients with drug-resistant focal onset seizures in the Netherlands. Journal of Medical Economics, 28(1), 114-123. https://doi.org/10.1080/13696998.2024.2443338

van Uittert, G., Hoogbergen, M., Beaudart, C., Li, N., Boers, M., & Hiligsmann, M. (2025). Patients' health related quality of life after massive weight loss reconstruction in the Netherlands. Expert Review of Pharmacoeconomics & Outcomes Research, 25(4), 517-526. https://doi.org/10.1080/14737167.2024.2393328

Geusens, P., van den Bergh, J., Roux, C., Chapurlat, R., Center, J., Bliuc, D., Wyers, C., Javaid, M. K., Li, N., Whittier, D., & Lems, W. F. (2024). The Fracture Phenotypes in Women and Men of 50 Years and Older with a Recent Clinical Fracture. Current Osteoporosis Reports, 22(6), 611-620. https://doi.org/10.1007/s11914-024-00885-z

Al Meslamani, A. Z., & Li, N. (2024). Assessing the economic impact of digital endpoints on medication adherence. Expert Review of Pharmacoeconomics & Outcomes Research, 24(7), 783-785. https://doi.org/10.1080/14737167.2024.2334893

Li, N., Jorgensen, N. R., Reginster, J.-Y., & Hiligsmann, M. (2024). The impact of bone turnover marker on medication adherence and the health economics-related consequences. Expert Review of Pharmacoeconomics & Outcomes Research, 24(7), 787-790. https://doi.org/10.1080/14737167.2024.2337718

Li, N., van den Bergh, J. P., Boonen, A., Wyers, C. E., Bours, S. P. G., & Hiligsmann, M. (2024). Cost-effectiveness analysis of fracture liaison services: a Markov model using Dutch real-world data. Osteoporosis International, 35(2), 293–307. https://doi.org/10.1007/s00198-023-06924-2

Maas, L., Boonen, A., Li, N., Wyers, C. E., Van den Bergh, J. P., & Hiligsmann, M. (2024). Cost-effectiveness of a multicomponent-adherence intervention in fracture liaison services. Expert Review of Pharmacoeconomics & Outcomes Research, 24(8), 987-996. https://doi.org/10.1080/14737167.2024.2366439

Beaudart, C., Li, N., Boonen, A., & Hiligsmann, M. (2023). Burden of osteoarthritis in the Netherlands: a scoping review. Expert Review of Pharmacoeconomics & Outcomes Research, 23(10), 1147-1167. https://doi.org/10.1080/14737167.2023.2260562

Li, N. N., Beaudart, C., Cauley, J. A., Ing, S. W., Lane, N. E., Reginster, J., Silverman, S., Singer, A. J., & Hiligsmann, M. (2023). Correction to: Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review. Pharmacoeconomics, 41(4), 393-393. https://doi.org/10.1007/s40273-023-01255-w

Li, N. N., Beaudart, C., Cauley, J. A., Ing, S. W., Lane, N. E., Reginster, J. Y., Silverman, S., Singer, A. J., & Hiligsmann, M. (2023). Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review. Pharmacoeconomics, 41(4), 363-391. https://doi.org/10.1007/s40273-022-01239-2